Cargando…
Pharmacological Basis for the Use of Evodiamine in Alzheimer’s Disease: Antioxidation and Antiapoptosis
Evodiamine (Evo), a major alkaloid compound isolated from the dry unripened fruit of Evodia fructus, has a wide range of pharmacological activities. The present study sought to explore the neuroprotective effects of Evo in l-glutamate (l-Glu)-induced apoptosis of HT22 cells, and in a d-galactose and...
Autores principales: | Zhang, Yongfeng, Wang, Jiaqi, Wang, Chunyue, Li, Zhiping, Liu, Xin, Zhang, Jun, Lu, Jiahui, Wang, Di |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983845/ https://www.ncbi.nlm.nih.gov/pubmed/29883380 http://dx.doi.org/10.3390/ijms19051527 |
Ejemplares similares
-
Pharmacological Basis for Use of Armillaria mellea Polysaccharides in Alzheimer's Disease: Antiapoptosis and Antioxidation
por: An, Shengshu, et al.
Publicado: (2017) -
Pharmacological basis for application of scutellarin in Alzheimer's disease: Antioxidation and antiapoptosis
por: Hu, Xinyu, et al.
Publicado: (2018) -
Pharmacological Actions of Multi-Target-Directed Evodiamine
por: Yu, Hui, et al.
Publicado: (2013) -
Magnolin Protects against Contrast-Induced Nephropathy in Rats via Antioxidation and Antiapoptosis
por: Wang, Feng, et al.
Publicado: (2014) -
Tetramethylpyrazine Protects Endothelial Injury and Antithrombosis via Antioxidant and Antiapoptosis in HUVECs and Zebrafish
por: Zhang, Yafang, et al.
Publicado: (2022)